Login / Signup

Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis.

Jiasheng WangYeseong Kim
Published in: International journal of hematology (2020)
Daratumumab is associated with lower risk of VTE in clinical trials.
Keyphrases
  • multiple myeloma
  • clinical trial
  • venous thromboembolism
  • randomized controlled trial
  • open label
  • study protocol
  • phase iii